- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced Biliary Cancer
Total 56199 results
-
Tongji HospitalRecruitingHepatocellular Carcinoma | Biliary Tract CancerChina
-
Sun Yat-sen UniversityRecruitingBiliary Tract Cancer | Radiotherapy | ImmunotherapyChina
-
Asan Medical CenterRecruitingHepatocellular Carcinoma | Biliary Tract CancerKorea, Republic of
-
University of PisaAzienda Ospedaliero, Universitaria PisanaUnknownGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Colo-rectal Cancer | Liver Cancer | Biliary Tract Cancer | Gall Bladder CancerItaly
-
Hospital Universitari de BellvitgeHospital Universitario Ramon y Cajal; Complejo Hospitalario de Navarra; University... and other collaboratorsNot yet recruitingBiliary Tract Neoplasms | Malignant Biliary Obstruction | Pancreatic Cancer Non-resectableSpain
-
Jazz PharmaceuticalsRecruitingBiliary Tract Cancer | HER2 Gene MutationUnited States, Puerto Rico
-
Shanghai Zhongshan HospitalRecruitingBiliary Tract Cancer | Candonilimab | Claudin 18.2China
-
Shanghai Jiahui International HospitalShanghai Zhongshan HospitalRecruitingAdvanced Biliary Tract CarcinomaChina
-
Institute of Oncology LjubljanaRecruitingTrace Element DeficiencySlovenia
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingColon Cancer | Pancreas Cancer | Biliary Tract CancerItaly
-
The Christie NHS Foundation TrustCompletedCholangiocarcinoma | Biliary Tract Cancer | Gallbladder Cancer | Ampullary CancerUnited Kingdom
-
The Christie NHS Foundation TrustCancer Research UKCompletedCholangiocarcinoma | Biliary Tract Cancer | Gallbladder Cancer | Ampullary CancerUnited Kingdom
-
First People's Hospital of HangzhouNot yet recruitingBiliary Tract Cancer | Gemcitabine | Immune Checkpoint InhibitorsChina
-
Institut für Klinische Krebsforschung IKF GmbH...Medizinische Hochschule Hannover, Germany, Prof. Dr. Arndt Vogel; MSD Sharp...RecruitingBiliary Tract Cancer | HER2 Gene MutationGermany
-
Second Affiliated Hospital, School of Medicine,...Guangzhou Burning Rock Dx Co., Ltd.RecruitingPancreatic Cancer | Liver Cancer | Biliary Tract CancerChina
-
Zhejiang Cancer HospitalRecruitingGastric Cancer | Colorectal Cancer | Pancreatic Adenocarcinoma | Biliary Tract Cancer | Gastroesophageal Junction Adenocarcinoma | Liver Cancer Stage IVChina
-
H. Lee Moffitt Cancer Center and Research InstituteBayerCompletedCancer of the Bile DuctUnited States
-
Asan Medical CenterRecruitingBiliary Tract Cancer | DNA Damage Repair DeficiencyKorea, Republic of
-
Kansai Hepatobiliary Oncology GroupUnknownBiliary Tract CancerJapan
-
Samsung Medical CenterTerminatedBiliary Tract Cancer
-
Kansai Hepatobiliary Oncology GroupCompleted
-
National Cancer Institute (NCI)TerminatedAdvanced Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Recurrent Extrahepatic Bile Duct Cancer | Recurrent Gallbladder Cancer | Unresectable Extrahepatic Bile Duct Cancer | Unresectable Gallbladder Cancer | Cholangiocarcinoma... and other conditionsUnited States
-
Nataliya UbohaGilead Sciences; University of Wisconsin, Madison; Arcus Biosciences, Inc.RecruitingCholangiocarcinoma | Bile Duct Cancer | Biliary Tract CarcinomaUnited States
-
The Affiliated Hospital of Xuzhou Medical UniversityRecruiting
-
Medinol Ltd.Completed
-
PfizerTerminatedAdvanced Solid Tumors | Advanced CancerUnited States
-
University Health Network, TorontoActive, not recruitingBreast Cancer | Advanced Solid CancersCanada
-
Hospital Universitari de BellvitgeHospital Universitario Ramon y Cajal; Hospital Mutua de Terrassa; Hospital del... and other collaboratorsCompletedPancreatic Cancer | Biliary Tract Neoplasms | Biliary ObstructionSpain
-
National Cancer Institute (NCI)CompletedHepatocellular Carcinoma | Biliary Tract Neoplasms | Liver Cancer | Biliary Cancer | Heptocellular CancerUnited States
-
Shanghai Zhongshan HospitalActive, not recruitingBiliary Tract Cancer | PD-1 Antibody | Lenvatinib | GemoxChina
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
AstraZenecaCompletedMelanoma | Breast Cancer | Colorectal Cancer | Pancreatic Adenocarcinoma | Lung Cancer | Head and Neck Carcinoma | Biliary Tract Cancer | Gastroesophageal CancerUnited States
-
University Health Network, TorontoUniversity of UlmRecruiting
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerFrance, United States, Spain, Canada, Argentina, Chile, Italy
-
Bristol-Myers SquibbTerminatedAdvanced CancerUnited States, Netherlands, Australia, Belgium, Canada, Italy, United Kingdom
-
Merck Sharp & Dohme LLCCompleted
-
Peter MacCallum Cancer Centre, AustraliaCompleted
-
OnxeoCompletedAdvanced CancerFrance, Belgium
-
Bristol-Myers SquibbCompleted
-
Case Comprehensive Cancer CenterCompleted
-
Bristol-Myers SquibbCompletedAdvanced CancerUnited States, Canada, Italy, Netherlands, Spain, Israel
-
Five Prime Therapeutics, Inc.ParexelCompleted
-
BeiGeneCompletedAdvanced CancerUnited States, Taiwan, Australia, Korea, Republic of, New Zealand
-
Bristol-Myers SquibbCompletedAdvanced CancerUnited States, Belgium, Canada
-
Royal Marsden NHS Foundation TrustAstraZeneca; Institute of Cancer Research, United KingdomCompleted
-
Eli Lilly and CompanyCompletedAdvanced CancerSwitzerland
-
Seoul National University HospitalAsan Medical Center; Ulsan University Hospital; Korea University Anam Hospital; Ewha Womans University Mokdong Hospital and other collaboratorsCompletedAdvanced CancerKorea, Republic of
-
Celldex TherapeuticsCompletedAdvanced CancerUnited States
-
Merck Sharp & Dohme LLCCompleted